Učitavanje...
Subgroup-specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination
A Bayesian design is presented that does precision dose-finding based on time to toxicity in a phase I clinical trial with two or more patient subgroups. The design, called Sub-TITE, makes sequentially adaptive subgroup-specific decisions while possibly combining subgroups that have similar estimate...
Spremljeno u:
| Izdano u: | Pharm Stat |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6640643/ https://ncbi.nlm.nih.gov/pubmed/30112806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1891 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|